NCR Online Journal

Lexston Signs MOU With Alvarius And Panacea To Expand In Natural And Psychoactive Products

 Breaking News
  • No posts were found

Lexston Signs MOU With Alvarius And Panacea To Expand In Natural And Psychoactive Products

January 19
08:12 2022
Lexston Life Sciences Corp. will be expanding in natural and psychoactive products after signing MOU with Alvarius and Panaces.

Lexston Life Sciences Corp. is passionate about people, plants, and the different processes that allow them to live in harmony and also heal accordingly. The company aims to make psychedelics available for all. It will enable the plants and individuals to live harmoniously.

The company announced the signing of a Memorandum of Understanding between its subsidiary Egret Bioscience Ltd and Alvarius Research Inc for conserving and conducting genomic research development for the Colorado River toad. Egret and Alvarius will look for ways to find the biosynthetic pathways leading to the tryptamines (5-MeO-DMT, 5-MeO-tryptamine, 5-HO-N-methyltryptamine, Bufotenin, and DMT) made in the parotoid glands of the toads.  

“With these biosynthetic toad tryptamines, immense pressure will be lifted off toad populations for supplying therapeutic psychoactive compounds. Since there is no alternative source for these gland secretions, it put immense pressure on the wild toad population. These secretions are of help to improve the psychological health of humans. Works are also on to conserve the wild population of toads. As a result, one can understand this is a regenerative business model.”

To provide a biosynthetic supply to these important therapeutic programs, in addition to stimulating needed research into the conservation status of wild populations, links our business success to improved outcomes for the toad. It is a regenerative business model” Dr. Philippe Henry, Chief Science Officer and Director of Lexston.

The company also signed an MOU with Panacea Plant Sciences Inc for developing new techniques for natural products like psychedelic containing lifeforms and cannabis. Under this joint venture, they will develop a supply chain, and decrease the supply cost of the compounds. The mission is to develop cell-based culture systems for producing psychedelic formulations. 

With this expansion, Lexston will be able to expand in the genetic and chemical analysis of natural products and psychedelics. 

For more details, visit: https://lexston.ca

About Lexston Life Sciences Corp. 

Lexston is passionate about people, plants, and the different processes that allow them to live in harmony and also heal accordingly. The company aims to make psychedelics available for all. 

Disclaimer: This article is purely for informational purposes and is not a recommendation in any way to buy or sell stocks.

Media Contact
Company Name: Lexston Life Sciences Corp
Contact Person: Admin at Lexston
Email: Send Email
Country: Canada
Website: lexston.ca

Related Articles